HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[HBcAg antibodies in acute viral hepatitis B in adults and infants in the 1st year of life].

Abstract
The study was carried out with blood sera from 122 patients with viral hepatitis B (94 adults and 28 infants). The specific markers of hepatitis B virus (HBsAg, anti-HBs, anti-HBc) were tested in the time course of the disease at 10-day intervals in the acute period and for a year after the discharge. Radioimmunoassay (RIA) revealed anti-HBc in the blood of adults and infants suffering from hepatitis B both in the presence and absence of HBsAg. Anti-HBc titres were mostly high (over 1:1500) in the acute period of the disease and persisted at high levels (1:1900) for a year after the acute disease. Anti-HBc titres were found to correlate with the severity of the disease: low titres (1:500) were detected only in severe cases. Anti-HBc demonstrated in the blood from the first days of the disease belonged to immunoglobulins M. A group of patients with hepatitis B was examined in the acute period for anti-HBc only in the absence of HBsAg and anti-HBs by RIA. In convalescence all these patients developed anti-HBsAg. No fatal outcomes were observed.
AuthorsE S Ketiladze, N P Bugaeva, T E Vorozhbieva, T P Kozlova, N N Zhilina
JournalVoprosy virusologii (Vopr Virusol) 1983 May-Jun Issue 3 Pg. 311-3 ISSN: 0507-4088 [Print] Russia (Federation)
Vernacular TitleAntitela k HBcAg pri ostrom virusnom gepatite B u vzroslykh i deteĭ 1-go goda zhizhi.
PMID6613087 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Core Antigens
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral (analysis)
  • Convalescence
  • Hepatitis B (diagnosis, immunology)
  • Hepatitis B Antibodies (analysis)
  • Hepatitis B Core Antigens (immunology)
  • Humans
  • Infant
  • Middle Aged
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: